Y-Intercept (HK)’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$675K Buy
+193,376
New +$858K 0.01% 1181
2026
Q2
– Sell
-60,847
Closed -$139K – 1843
2026
Q1
$139K Buy
60,847
+16,098
+36% +$51.1K ﹤0.01% 1452
2025
Q4
$179K Buy
+44,749
New +$249K ﹤0.01% 1447
2024
Q3
– Sell
-55,173
Closed -$1.05M – 1459
2024
Q2
$1.05M Buy
+55,173
New +$1.41M 0.06% 467

Other funds holding EVH

Y-Intercept (HK)'s EVH Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Evolent Health (EVH) in Q3 2026: 193,376 shares worth $675K. The stake represents 0.01% of the portfolio and ranks #1181 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in EVH as recently as Q1 2026.

Y-Intercept (HK) first reported a position in EVH in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.05M in Q2 2024. 19 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

  • Y-Intercept (HK) held 193,376 shares of Evolent Health worth $675K as of Q3 2026.
  • Evolent Health was a new Y-Intercept (HK) position in Q3 2026.
  • Evolent Health made up 0.01% of Y-Intercept (HK)'s portfolio in Q3 2026, its #1181 holding.
  • Y-Intercept (HK) first reported a position in Evolent Health in Q2 2024 and has held it in 4 quarters since.
  • Y-Intercept (HK)'s Evolent Health position peaked at $1.05M in Q2 2024.
  • 19 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.